Skip to Content

Telavancin

In the US, Telavancin (telavancin systemic) is a member of the drug class glycopeptide antibiotics and is used to treat Nosocomial Pneumonia, Pneumonia and Skin and Structure Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01XA03

CAS registry number (Chemical Abstracts Service)

0372151-71-8

Chemical Formula

C80-H106-Cl2-N11-O27-P

Molecular Weight

1755

Therapeutic Category

Glycopeptide antibacterial

Chemical Names

N3''-[2-(Decylamino)etyl)-29-[[(phosphonometyl)amino]metyl]vancomycin

(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoetyl)-10,19-dichloro-44-[(3-{[2-(decanylamino)etyl]amino}-2,3,6-trideoxy-3-C-etyl-α-L-lyxo-hexopyranosyl-(1->2)-beta-D-glucopyranosyl)oxy]-7,22,28,30,32-pentahydroxy-6-[(2R)-4-metyl-2-(metylamino)pentaamido] (WHO)

Foreign Names

  • Telavancinum (Latin)
  • Telavancin (German)
  • Télavancine (French)
  • Telavancina (Spanish)

Generic Names

Brand Names

  • Vibativ
    Astellas, Spain; Astellas, Lithuania; Clinigen, Poland; Theravance, United States; Clinigen, Germany; Clinigen Healthcare, United Kingdom

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide